Roivios, a pioneering clinical-stage medical device company dedicated to revolutionizing kidney health, proudly announces that its research and development arm, 3ive Labs, has secured approval for an ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Dizal announces positive pooled data of sunvozertinib in EGFR TKI-resistant NSCLC: Shanghai, China Friday, December 13, 2024, 18:00 Hrs [IST] Dizal, a biopharmaceutical company co ...

A new study published in the Journal of Clinical Endocrinology and Metabolism showed that among type 2 diabetes mellitus ...

The FDA delays Johnson & Johnson's SC amivantamab approval for NSCLC over facility inspection issues, unrelated to product ...

Among Taiwan’s non-small cell lung cancer cases, approximately 55 percent involve an EGFR mutation, with deletion of exon 19 and exon 21 the most common mutations, treatable with first to ...

Johnson & Johnson JNJ announced that the FDA has issued a complete response letter (“CRL”) to its biologics license ...

Investigators studied the prevalence, predictors, and outcomes of complete functional recovery after radical nephrectomy.

Study demonstrates how metabolic imaging differentiates high and low oxidative phosphorylation (OXPHOS) subtypes of ...

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

Single Arsenic and Cadmium exposure is positively associated with increased CKD risk, reports a study published in the Environmental Geochemistry and Health.Environmental exposure to arsenic ...

Chronic kidney disease is not uncommon among patients with PsA, with risk factors including diabetes and NSAID use, while methotrexate use offered protective benefits.